JOHANNESBURG (Reuters) – A South African study has shown the Johnson & Johnson COVID-19 vaccine offers over 90% protection against death, the joint lead investigator for the country’s J&J trial, Glenda Gray, said on Friday.
“We can report that the single jab J&J vaccine protected between 91% to 96.2% of healthcare workers against death,” Gray said.
“This was our primary endpoint and we are able to say this vaccine protected health workers against death.”
(Reporting by Olivia Kumwenda-Mtambo; editing by Jason Neely)
